Overview
Extended phenotyping determines presence/absence of clinically significant antigens beyond ABO and RhD (commonly C, c, E, e, K, and additional systems as ordered).
Clinical Importance
Select antigen-negative units for patients with alloantibodies
Prophylactic matching in sickle cell disease and other chronic transfusion programs
Specimen Requirements
- Specimen: whole blood (EDTA preferred for most typing, screens, and crossmatches)
- Tube: lavender/pink-top K₂EDTA (follow institutional blood bank tube color policy)
- Identity: two unique patient identifiers; many sites require a witnessed/type-and-screen collection process
- Handling: mix gently; do not use grossly hemolyzed specimens for serologic interpretation without investigation
- Timing: specimen age limits for pretransfusion testing are SOP-/standards-defined (commonly ≤3 days for patients who may have been transfused or pregnant recently; verify local AABB-aligned policy)
Analytical Method
Patient or donor red cells are tested with typed antisera (tube/gel/solid-phase) or predicted by DNA-based blood group genotyping when serology is limited (recent transfusion, DAT-positive cells).
Instruments Used
Automated analyzers
- Ortho Vision / Ortho Clinical Diagnostics automated immunohematology systems
- Bio-Rad IH-1000 / IH-500 and related gel/column systems
- Grifols Erytra / Wadiana automated blood typing systems
- Immucor NEO / Echo luminescent immunohematology systems
- Manual tube testing with centrifugation and macroscopic reading
- Column agglutination (gel/bead) card systems
- Solid-phase red cell adherence platforms
Manual methods
- Manual tube testing with immediate-spin and AHG phases as applicable
Reference Values
Immunohematology interpretations follow institutional SOPs aligned with AABB Standards, ISBT terminology, and applicable CLSI / BSH guidance. Reagent lots, method (tube, gel, solid-phase), and patient history critically affect results; always verify against the performing laboratory’s current procedure and applicable standards edition.
Each antigen is reported as positive or negative (or molecular predicted phenotype). No numeric reference interval.
Interpretation
Common Causes of Increased Results
- Antigen positive; patient expresses the antigen; cannot form alloantibody to that antigen (barring rare variants)
Common Causes of Decreased Results
- Antigen negative; patient may form alloantibody if exposed; donor units for matching must lack the antigen when antibody is present
Clinical Significance
- Alloimmunized patient support
- Sickle cell / thalassemia transfusion programs
- Antibody identification correlation
Factors Affecting Results
Pre-analytical
- Recent transfusion causing mixed-field / misleading phenotype
Analytical
- DAT-positive cells interfering with typing
- Antiserum potency/QC failures
Post-analytical
- Incomplete antigen requirements entered into the LIS
Advantages and Limitations
Advantages
- Guides precise unit selection
- Reduces further alloimmunization when used prophylactically
Limitations
- Labor-intensive when many antigens required
- Serology unreliable after recent transfusion; genotype preferred
Clinical Pearls
If the patient was transfused last week, stop serologic phenotyping early; genotype or pretransfusion samples tell the truth.
References
Authoritative textbooks, guidelines, and reviews supporting this laboratory test reference. Verify reference intervals, critical limits, and method details against institutional protocols and current guideline editions.
Textbooks
- Cohn CS, Delaney M, Johnson ST, Katz LM, eds. Technical Manual. 21st ed. AABB; 2023.
- Fung MK, Eder AF, Spitalnik SL, Westhoff CM, eds. Technical Manual. 20th ed. AABB; 2020.
- Harmening DM. Modern Blood Banking & Transfusion Practices. 7th ed. F.A. Davis; 2019.
- McPherson RA, Pincus MR. Henry's Clinical Diagnosis and Management by Laboratory Methods. 24th ed. Elsevier; 2021.
- Bain BJ, Bates I, Laffan MA, eds. Dacie and Lewis Practical Haematology (verify current edition). Blood transfusion chapters.
CLSI and Professional Guidelines
- AABB. Standards for Blood Banks and Transfusion Services (verify current edition and institutional adoption).
- U.S. Food and Drug Administration. Code of Federal Regulations Title 21 . Blood and Blood Components (verify current institutional adoption).
- World Health Organization. Blood safety and availability / transfusion guidance (verify current WHO publication and institutional adoption).
- Clinical and Laboratory Standards Institute. Related immunohematology and specimen identity standards (verify current documents and institutional adoption).
- International Society of Blood Transfusion (ISBT). Blood group terminology and transfusion guidance (verify current ISBT publications).
- British Society for Haematology (BSH). Guidelines for blood grouping, antibody testing, and transfusion practice (verify current BSH guideline editions).
- Clinical and Laboratory Standards Institute. Immunohematology, specimen identification, and related transfusion laboratory documents (verify current CLSI editions).
WHO Publications
- World Health Organization. Blood safety, availability, and clinical transfusion guidance (verify current WHO publication).
Frequently Asked Questions
Common questions about using this Extended Phenotyping laboratory test Medical Laboratory Library reference in Medical Laboratory Science education.
What is the Extended Phenotyping laboratory test reference used for?
This Medical Laboratory Library page summarizes the clinical importance of Extended Phenotyping. Review the Clinical Importance section for why the test is ordered in laboratory medicine practice.
Where can I find Extended Phenotyping specimen requirements?
See the Specimen Requirements section on this page for specimen information related to Extended Phenotyping. Confirm collection details against your laboratory protocol.
Where are Extended Phenotyping reference values listed?
See the Reference Values section on this Laboratory Library page. Reference ranges can vary by method and population, so verify intervals with your laboratory.
How do I interpret Extended Phenotyping results?
Use the Interpretation section for laboratory interpretation framing, including increased and decreased result patterns when provided. Do not treat educational text as a patient-specific diagnosis.
What analytical method is used for Extended Phenotyping?
See the Analytical Method section for principle and method notes. Method details may differ by instrument and institutional SOP.
Are related laboratory tests linked from Extended Phenotyping?
Yes. The Related Laboratory Tests section lists connected references for continued lookup in the Medical Laboratory Library.
How can I continue learning after reading Extended Phenotyping?
Use Continue learning links on this page for related Academy lessons, medical laboratory quizzes, or laboratory case studies when available for this Blood Bank / Transfusion Medicine topic.
What are the clinical pearls for Extended Phenotyping?
See the Clinical Pearls section for concise laboratory practice notes associated with Extended Phenotyping. Apply pearls alongside institutional protocols.
Reading progress
Awards XP once after you have meaningfully reviewed this article.